Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NVS NYSEARCA:XLV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$153.78+0.7%$151.41$112.34▼$170.46$293.40B0.452.16 million shs2.59 million shsXLVHealth Care Select Sector SPDR Fund$161.09-0.4%$153.48$127.96▼$165.60$41.35B0.5612.33 million shs9.16 million shs10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis0.00%-0.18%+4.49%+1.17%+29.84%XLVHealth Care Select Sector SPDR Fund0.00%+0.16%+7.82%+8.26%+19.99%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$153.78+0.7%$151.41$112.34▼$170.46$293.40B0.452.16 million shs2.59 million shsXLVHealth Care Select Sector SPDR Fund$161.09-0.4%$153.48$127.96▼$165.60$41.35B0.5612.33 million shs9.16 million shs10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis0.00%-0.18%+4.49%+1.17%+29.84%XLVHealth Care Select Sector SPDR Fund0.00%+0.16%+7.82%+8.26%+19.99%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVSNovartis 2.31Hold$141.20-8.18% DownsideXLVHealth Care Select Sector SPDR Fund 2.78Moderate Buy$161.09N/ACurrent Analyst Ratings BreakdownLatest NVS and XLV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2026NVSNovartis Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (A-) ➝ Buy (B)(Data available from 7/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVSNovartis$54.53B5.38$10.74 per share14.32$22.04 per share6.98XLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVSNovartis$13.98B$6.9822.0315.852.6524.87%38.82%15.16%7/21/2026 (Estimated)XLVHealth Care Select Sector SPDR FundN/AN/A21.15N/AN/AN/AN/AN/AN/ALatest NVS and XLV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/21/2026Q2 2026NVSNovartis$2.17N/AN/AN/A$14.07 billionN/A4/27/2026Q1 2026NVSNovartis$2.11$1.99-$0.12$1.65$13.44 billion$13.52 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthNVSNovartis$3.082.00%+5.28%44.13%N/AXLVHealth Care Select Sector SPDR Fund$2.531.57%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVSNovartis0.960.850.65XLVHealth Care Select Sector SPDR FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVSNovartis13.12%XLVHealth Care Select Sector SPDR FundN/AInsider OwnershipCompanyInsider OwnershipNVSNovartis0.01%XLVHealth Care Select Sector SPDR FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVSNovartis75,2671.91 billion1.91 billionOptionableXLVHealth Care Select Sector SPDR FundN/A256.71 millionN/ANot OptionableNVS and XLV HeadlinesRecent News About These CompaniesXLV: Healthcare Sector On The Mend, But Probably Not For LongJuly 18 at 9:00 AM | seekingalpha.comSeeking Alpha’s quant spotlight: Highest and lowest rated healthcare stocks ahead of Q2July 17 at 10:31 PM | msn.comDrug Pipeline Wins State Street Over on HealthcareJuly 14, 2026 | etftrends.comEHealthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD SurgeJuly 14, 2026 | zacks.comQ2 Earnings Preview: Tech & Energy Drive Growth Amid Healthcare HeadwindsJuly 13, 2026 | etftrends.comEWhich is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?July 11, 2026 | fool.comNot Just Tech: Invest in Innovation With HealthcareJuly 9, 2026 | etftrends.comEStocks Look Shaky, But This Sector is Booming (Biotech)July 9, 2026 | zacks.comTwo Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%July 9, 2026 | 247wallst.comHealthcare breadth hits 15-year high, but XLV’s top holdings remain quant holdsJuly 8, 2026 | msn.com4 Defensive Stocks to Take Refuge in as Tech Sell-off ContinuesJuly 8, 2026 | zacks.comWeak June Jobs Data Likely to Boost These ETF AreasJuly 6, 2026 | zacks.comState Street Health Care ETF Tops Invesco Pharma on Cost and SizeJuly 4, 2026 | fool.comSPDR Health Care ETF Tops iShares Biotech in Long-Term ReturnsJuly 2, 2026 | aol.comAAnxious About an AI Bubble? ETFs to Help Navigate the RiskJune 30, 2026 | zacks.comBiotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week HighsJune 29, 2026 | zacks.comHealth Care Select Sector SPDR ETF declares quarterly distribution of $0.6563June 22, 2026 | msn.comETF Ways to Navigate the 2026 Midterm Election CycleJune 22, 2026 | zacks.comShould You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?June 22, 2026 | zacks.comThe 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026June 21, 2026 | 247wallst.comThese Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)...May 18, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVS and XLV Company DescriptionsNovartis NYSE:NVS$153.78 +1.05 (+0.69%) Closing price 07/17/2026 03:59 PM EasternExtended Trading$153.45 -0.33 (-0.21%) As of 07/17/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.Health Care Select Sector SPDR Fund NYSEARCA:XLV$161.09 -0.71 (-0.44%) Closing price 07/17/2026 04:10 PM EasternExtended Trading$161.19 +0.10 (+0.06%) As of 07/17/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/13- 07/17 Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Why Wall Street Suddenly Sees SpaceX as an AI Company Shopify's Quiet AI Strategy Could Be Its Biggest Advantage Yet TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
